Callisto Investor Challenges Proposed Synergy Merger
An institutional investor on Thursday filed a putative class action against Callisto Pharmaceuticals Inc. in New York state court, trying to block a proposed merger with Synergy Pharmaceuticals Inc. that would...To view the full article, register now.
Already a subscriber? Click here to view full article